Back

Risk of major adverse cardiovascular events after RSV-related hospitalization among US adults with heart failure

30 August 2026 (12:15 - 13:00)
Organised by: Logo
Congress Presentation Part of: Heart failure risk: from inflammation to prediction Epidemiology, Prognosis, Outcome ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Professor Deepak Bhatt

Icahn School of Medicine at Mount Sinai, New York City (United States of America)

6 More presentations in this session

Presentation thumbnail
Sex differences in cardiovascular inflammation defined by high-sensitivity C-reactive protein across heart failure phenotypes: insights from POSEIDON
Professor S. Stoerk (Wuerzburg, DE)
Abstract Slides Video
Presentation thumbnail
From desalination to deficiency: shifting magnesium-related mortality in heart failure patients
Doctor K. Faierstein (Ramat Gan, IL)
Abstract Slides Video
Presentation thumbnail
Does evidence-based treatment recommendations implementation improve 1-year outcomes in patients with heart failure?
Doctor M. Anguita Gamez (Madrid, ES)
Abstract Slides Video
Presentation thumbnail
Prevalence of high inflammatory risk across heart failure subtypes in Europe: a sub-analysis of the global POSEIDON study
Professor J. Muller-Ehmsen (Bremen, DE)
Abstract Slides Video
Presentation thumbnail
Sex differences in cardiorenometabolic syndrome across heart failure: prognostic impact in a low-middle income country
Doctor A. Jordan (Mexico City, MX)
Abstract Slides Video

Access the full session

Session thumbnail
Heart failure risk: from inflammation to prediction

The Event

Event poster

ESC Congress 2026

30 August 2026 12:15 CET
You may be interested in
thumbnail
Congress Presentation
Short- and long-Term mortality in patients hospitalized for dyspnea with acute heart failure, respiratory infection, or both: insights from the PARADISE cohort
10 May 2026
thumbnail
Congress Presentation
Effectiveness of bivalent RSV prefusion F protein-based vaccine in individuals with and without atrial fibrillation: a prespecified analysis of the DAN-RSV trial
28 August 2026
thumbnail
Congress Presentation
Machine learning for development of ECG-based prediction models for atrial fibrillation, thromboembolism and mortality in patients with heart failure
8 April 2024
thumbnail
Congress Presentation
Long-term outcomes after acute coronary syndrome in patients with rheumatoid arthritis
28 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources